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In addition topossessing an extraordinary sweepingactivity, pulmonary alveolar macrophages (PAM) areequipped
withthebiochemicalmechanismsinvolvedinthemetabolismofcarcinogens, whichwerefoundtobeinducibleinhumans
by cigarette smoke. Moreover, several defense processes werestimulatedin ratPAMafterin vivoadministrationofthe
anticarcinogenN-acetycysteine (NAC). Benzolalpyrenediolepoxide(BPDE)-DNAadducts, asrevealedbysynchronous
fluorescencespectrophotometry, wereselectively detected inPAMofsmokersandpersistedupto6months. Theamount
ofadducts wassignifcntly atedwiththenumberofcurrentlysmokedcigarettesbutnotwiththecigrettes smoked
inalifetime (pack-years). Nevertheless, deviationsfromtheregressionlinepointedouttheroleofinterindividual variability
factors in adduct formation. Probably due to the low mitotic rate ofPAM in the respiratory lumen, the frequency of
micronuclei wasnotenhancedinsmokers. However, parallelassaysin ratsshwed thatmicronucleicanbeenhancedafter
massive intratracheal administmtion ofbenzolalpyrene orwhole-bodyexposuretohighamountsofmaiunstrem cigarette
smoke, whichalsoinducedBPDE-DNAadductsinlungcellsandotherorgans,includingtheheart. All theseadverseeffects
weremarkedlyinhibitedbytheoraladministration ofNAC,whichprovidesthepremiseandrationaleforafuturestudy
on the protective effects oforal NAC in heavy smokers.
Introduction
Amongthecellpopulationsthat may surrogatetargetcellsfor
biomonitoring purposes, pulmonary alveolar macrophages
(PAM) areofparticularinterest. Theselong-livingcellsprovide
aformidablebulwarkprotecting terminalairways, whichby far
represent the largest surface of communication between the
organismandtheenvironment. As many as24-120 x 106PAMin
humans(I)and0.75 x 106PAMinrats(2) areremoveddailyfrom
thealveolar spacesviathemucociliatory escalator. Thisgives an
ideaoftheextraordinary sweepingactivity ofthesecells, which
phagocytize inhaled particulate material, often containing car-
cinogensresultingfromtobaccosmokeand/orairpollution. Inad-
dition, PAMareequippedwiththeinduciblemetabolicmachinery
capableofactivatingbenzo[aJpyrene(BaP), which mayplayarole
in determining DNA damage in bronchial cells (3). However,
carcinogen-detoxifyingmechanisms arealsopresent(4,5),which
canbeinducedinhumansbycigarettesmoke(4)andinratsby an-
ticarcinogenic thiols, such asN-acetylcysteine (NAC) (6).
We areusing humanPAM, which canbecollected bybroncho-
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alveolar lavage (BAL), a commonly used clinical practice, to
assesstheoccurrenceofbenzo[a]pyrenediolepoxide(BPDE)-
DNAadductsandcytogeneticdamageinhumansanditsrelation-
shipwithcigarettesmoke(CS)andpossibleairpollutants. Addi-
tionally, weareperformingpilotstudiesinratsexposedtoeither
BaPorCStocheckthereliabilityofthesemodelsasbiomarkers
tobeexploitedinmonitoringchemopreventionclinicaltrials.
Materialsand Methods
Subjects, BALPerformance, andRecoveryofPAM
BALwasperformedaccordingtoastandardizedtechnique(7)
from 39 individuals in the study ofBPDE-DNA adducts and,
separately, from31 individuals inthestudy onmicronuclei. The
characteristics ofall these subjects, i.e., age, sex, occupation,
currentdisease, andsmokinghabits, havealreadybeenpresented
in tabulated form (8,9). The cell pellet was recovered by cen-
trifugation oftheBALfluid. Thenumberofcellsrecoveredfrom
eachsubjectrangedbetween2.9and31.6 x 106, beingmorethan
twiceinsmokerscompared tononsmokersandex-smokers. On
an average, PAM accounted for90% ofBALcellularity.
TreatmentofAnimals
Groups ofmale Sprague-Dawley rats (Morini strain), each
composed of six animals, were treated intratracheally for 3DE FLORA ETAL.
consecutive days with BaP (Sigma) (25 mg/kg body weight) in
Tween 80aqueousvehicle, orbygavagewithNAC(Zambon) (1
g/kg body weight) in phosphate-buffered saline, pH 7.4, 5 hr
before each BaP instillation. Suitable controls ofTween 80 in-
tratracheally and NAC per os were also included. In other
studies, groupsofratswereeitheruntreatedorexposedfor3or8
consecutivedays (60-120min/day), inachamber(capacity: 20
L) containing the mainstream smokeofcommercially available
cigarettes. Half of CS-exposed animals were pretreated with
NACperos. The animals were killed 24 hr afterthe last treat-
ment, and BAL was immediately performed by means offive
10-mL infusions of saline. At the same time, bone marrow
smears were prepared for cytogenetic analysis, and lungs and
liver were removed for evaluation ofBPDE-DNA adducts.
Evaluation ofBPDE-DNA Adducts
DNA was extracted from PAM as previously described (9),
and BPDE-DNA adducts were evaluated by means of syn-
chronous fluorescence spectrophotometry (SFS) (10). Toobtain
astandardized amountof40itg DNAtobeanalyzedby SFS, in
somecases, especially innonsmokers, theDNAextracted from
two to three individuals withhomogeneouscharacteristics was
pooled. Intotal, therefore, 27sampleswereobtainedasrepresen-
tativeofthe39subjectsunderstudy. Arbitrary fluorescenceunits
(FU) were used forquantifying BPDE-DNA adducts (9).
EvaluationofMicronucleatedandBinucleatedCells
Cytocentrifuge-prepared slides were fixed and stained by
means ofDiff-Quik (Merz + Dade). Micronucleated (MN) and
binucleated (BN) PAM werescored inblind-codedslidesby two
readers, eachoneexamining2-3000PAMata 1000x magnifica-
tion. Asshown inFigure 1, MNcanbeeasilydistinguished from
pigmented cytoplasmic granulesbyvirtueoftheirstructureand
nucleuslike staining patterns.
Results
Micronuclei in Human PAM
Theoverall frequencyofMN (mean + SD) in 31 subjects was
3.9 ± 1.8%0, without any significant difference between 11
smokers (3.4 ± 2.5%o) and20nonsmokers orex-smokers (4.1
+ 1.4%o). No particular trend could be related to age (18-74
years) or to sex (4.1 ± 2.1%o in22 males, and 3.3 ± 0.7%o in9
females), andnosignificantassociationcouldbeestablishedwith
occupation or pathological conditions.
BPDE-DNA Adducts in Human PAM
Detection ofBPDE-DNAadducts in27 samplesofPAMob-
tained from 39 individuals was selectively related to smoking
habits. Infact, noadduct wasdetectableby SFS insamplesfrom
13 nonsmokers and6ex-smokers, whohad stopped smoking at
least2 yearsbeforeBAL. Incontrast, the 84.7% ofsamplesob-
tanied from 16 current smokers exhibited evident SFS peaks.
Alsopositive werethetwopoolsofPAM obtainedfromfourin-
dividuals (formersmokers) whohadstopped smoking inthelast
1-6 months preceding BAL. As showninFigure2, the amounts
FIGURE 1. Appearance ofhuman micronucleated (MN) or binucleated (BN)
pulmonary alveolar macrophages, stained with Diff-Quik (original
magnification lOOOx).
ofBPDE-DNAadducts weresignificantly related, inspiteofim-
portant individual deviations from the regression line, to the
numberofcurrently smokedcigarettes. No significant relation-
ships couldbe conversely observed with pack-years.
PreventionbyNACofBaP-andCigaretteSmoke-
Induced Cytogenetic Damage in Rat PAM
Theintratracheal instillationofBaPinduceda5-foldincrease
inthefrequency ofMN as well as aconsiderable enhancement
of BN PAM. Pretreatment with NAC prevented these effects
(Table 1).
Whole-body exposureofrats tomainstream cigarette smoke
for3consecutivedaysdidnotenhancethefrequencyoftheseend
points, but after 8 days oftreatment both MN and BN cell fre-
quencies weresignificantlyenhanced. Again, administrationof
NAC by gavage prevented the smoke-induced cytogenetic
damage (Table 1).
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FIGURE 2. Correlation betwven the amount ofBPDE-DNAadducts in pul-
monary alveolarmacrophages and the numberofcurrently smoked cigaret-
tes/day orpack-years. Correlation coefficients (r) werecalculated amongcur-
rent smokers (U) only in the case of cigarettes/day, and among current
smokers plus former smokers (O) plus ex-smokers (A) inthecaseofpack-
years, (0) nonsmokers.
Table 1. Frequency (mean ± SD) ofmicronucleated and binucleated PAM
in variously treated Sprague-Dawley rats.
Treatment ofrats MN PAM, %O BN PAM, %O
Controls 2.0 ± 0.9 16.3 ± 3.5
BaPintratracheally 9.7 ± 1.1** 42.0± 11.1*
BaP intratracheally +NACperos 4.2 ± 0.91 15.0 ± 4.2t
Controls 3.2 ± 1.8 19.4 + 9.2
Smoke (3 days) 4.1 ±2.0 23.3 ± 9.5
Smoke (3 days) + NACperos 4.5 ± 1.3 29.2 ± 7.2
Smoke (8 days) 6.4 +2. 1* 35.9 ± 11.8*
Smoke (8 days) + NACperos 3.5 ± 1.6t 30.0 ± 8.6
Abbreviations: MN, micronucleated; BN, binucleated; PAM, pulmonary
alveolar macrophages; BaP, benzo[a]pyrene; NAC, N-acetylcysteine.
*p < 0.05 ascompared to controls.
**p < 0.001 as compared to controls.
p < 0.05 as compared to BaP-treated rats.
'p < 0.001 as compared to BaP-treated rats.
Discussion
TheresultshereinreportedprovideevidencethathumanPAM
represent anideal target forassessing carcinogen-DNAadducts
resulting fromcigarette smoke. Atvariancewithothersurrogate
cells, such asperipheral bloodleukocytes, inwhichadducts are
poorly relatedtosmokinghabits (11,12)andstronglyaffectedby
dietary carcinogens (13), PAM analysis could selectively
discriminate smokers from nonsmokers. Detection ofBPDE-
DNA adducts in these cells therefore provides a sensitive and
specifictoolinhumanbiomonitoring. Clearly, thisdoes notrule
outthepossibility thatapplication ofeven more sensitive tech-
niques, such as the 32P-postlabeling technique, may detect
carcinogen-DNA adductsinPAMduetoothersources, e.g., air
pollution or passive smoke. We are currently exploring this
possibility.
In spite ofthe significant correlation observed between the
amount of BPDE-DNA adducts and the number ofcurrently
smoked cigarettes, deviations from the regression line pointed
outtheroleofsmokingstyleandofinterindividual variability in
the local metabolism ofcarcinogens, which was previously in-
vestigated inhuman PAM (4) and lung peripheral parenchyma
(14,15). Theseconsiderations emphasizetheusefulnessofassess-
ing the internal dosimetry in exposed individuals.
Probably because of the low mitotic index of PAM in the
respiratory lumen, thefrequency ofMN waspoorly affectedby
the variability factors under study, including smoking habits.
Therefore, thiscytogenetic index is nota sensitivebiomarkerof
humanexposuretotheamounts ofclastogens normally inhaled
withcigarettesmoke. However, theparallelexperiments inrats
showedthatawhole-bodyexposuretohighdosesofmainstream
cigarettesmoke, whichmarkedly enhancedthefrequencyofMN
in bone marrow polychromatic erythrocytes in both mice (16)
and rats (this study), significantly increased MN in PAM. The
intratracheal administration ofhigh amountsofBaP, which con-
versely werenotclastogenic inbonemarrowcells, considerably
enhanced MNinPAM andalsoproducedtheformationofBPDE
adducts bothto lung and liver DNA (17). As shown by prelim-
inary results, exposureofratstocigarette smokealsocausesthe
formationofBPDE-DNAadductsdetectableby SFS inthelung
and other organs, including the heart (unpublished data).
Itisofinterestthatcytogeneticchangesandadductsproduced
byeitherBaPorcigarettesmokewereefficientlypreventedbythe
oraladministrationofthethiolNAC, ananticarcinogenworking
through multiple mechanisms (18,19). We are now planning to
monitorseveralendpoints, includingthosedescribedinthisarti-
cle,toevaluatetheprotectiveeffectsoforalNACinheavysmokers.
This manuscript was presented asaposterattheConferenceonBiomonitor-
ing and Susceptibility Markers in Human Cancer: Applications in Molecular
Epidemiology and Risk Assessment that washeld in Kailua-Kona, Hawaii, 26
October-l November 1991.
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